Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Not yet recruiting

GoFast CAR T-Cell Therapy for Recurrent Refractory B-Cell Lymphoma

NCT07670260

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT07669194

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Not yet recruiting

Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis

NCT07668895

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
Locations: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Safety and Efficacy of Renal Denervation for Untreated Grade I Hypertension: a Pilot Study

NCT07664787

Conditions: Cardiovascular Diseases, Grade 1, Hemic and Lymphatic Diseases, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

Study of Alternative and Approved Dosing Regimens of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Relapsed/Refractory Multiple Myeloma

NCT07614360

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma

NCT07247097

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not yet recruiting

Neurocognitive Assessment in Long-Term Survivors of Lymphoma

NCT07652476

Conditions: Classic Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +11 more
Locations: Clinica di Ematologia, AOU Ospedali Riuniti Ancona, Italy

Divisione di Oncologia e dei Tumori immuno-correlati - IRCCS Centro di Riferimento Oncologico di Aviano Aviano, Italy

U.O.C Ematologia - IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy

U.O.C. Ematologia Ospedale Civile di Legnano - ASST Ovest Milanese Legnano, Italy

View Trial Details

Not yet recruiting

GPRC5D Targeted PET/CT Imaging in Plasma Cell Disorders

NCT07660939

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma

NCT07658924

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

Molecular and Cellular Characterization of MALT Lymphoma

NCT07376330

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: IRCCS Ospedale San Raffaele Milan, Italy

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions